*Adverse events leading to study drug discontinuation: Immediate Switch: emergent to EFV/FTC/TDF—anxiety; insomnia; night sweatsDelayed Switch: emergent to ABC/3TC + EFV (baseline to Wk12)—depressionD
The median PFS for patients in the IFI and ENI groups was 11 months and 13 months, respectively; the 1-, 2-, and 3-year PFS rates for patients between the IFI and ENI groups were 43.8%, 23.6%, and 21.
Abbreviations: ALT, aminase; TBIL, total bilirubin level; IMRT, intensity-modulated radiotherapy; 3D-CRT, three-dimensional conformal radiotherapy. Incidence and type of acute toxicity developed in pa
*The preferred adverse event term used for “CF exacerbation” was “cystic fibrosis.”A patient may have been counted in more than one preferred term. Percentages were calculated using the total number o
